EU Commission to better define medtech directive scope: borderline and aesthetic issues
This article was originally published in Clinica
One of the European Commission’s key aims in the recast of the medical device directives is to ensure that there is much greater clarity about which products are regulated under the directives and which product areas do not come under their scope. Areas focus include products on the borderline with other directives, as well as implantables or other invasive devices without a medical purpose.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.
How to get non-CE-marked medical devices onto the UK market at speed